Maven Securities’s DexCom DXCM Stock Holding History

Maven Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-68,900	Closed	-$4.57M	–	447
2025 Q4	$4.57M	Buy	+68,900	New	+$4.45M	0.1%	192
2025 Q3	–	Sell	-10,400	Closed	-$908K	–	570
2025 Q2	$908K	Buy	+10,400	New	+$815K	0.02%	464
2025 Q1	–	Sell	-7,300	Closed	-$568K	–	840
2024 Q4	$568K	Sell	7,300 -4,200	-37%	-$311K	0.01%	547
2024 Q3	$771K	Buy	11,500 +2,000	+21%	+$164K	0.01%	563
2024 Q2	$1.08M	Buy	+9,500	New	+$1.2M	0.02%	507
2024 Q1	–	Sell	-27,000	Closed	-$3.35M	–	546
2023 Q4	$3.35M	Buy	27,000 +21,700	+409%	+$2.22M	0.07%	210
2023 Q3	$494K	Buy	5,300 +3,600	+212%	+$406K	0.01%	813
2023 Q2	$219K	Buy	+1,700	New	+$206K	﹤0.01%	802
2023 Q1	–	Sell	-3,000	Closed	-$340K	–	960
2022 Q4	$340K	Hold	3,000	–	–	0.01%	663
2022 Q3	$242K	Buy	+3,000	New	+$254K	﹤0.01%	1000
2022 Q1	–	Sell	-1,600	Closed	-$215K	–	998
2021 Q4	$215K	Buy	+1,600	New	+$230K	0.01%	757

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maven Securities's DXCM Position: Q1 2026 in Review

Maven Securities sold out of DexCom (DXCM) in Q1 2026, closing a stake of 26,696 shares — an estimated $1.77M sold.

Maven Securities first reported a position in DXCM in Q3 2018 and held it in 12 quarters. The position peaked at $1.85M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Maven Securities reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Maven Securities sold 26,696 DexCom shares in Q1 2026, an estimated $1.77M.
Maven Securities first reported a position in DexCom in Q3 2018 and held it in 12 quarters.
Maven Securities's DexCom position peaked at $1.85M in Q4 2020.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.